Cynosure Competitors and Similar CompaniesClear all

Cynosure's competitors and similar companies include STRATA Skin Sciences, Ellex, Erchonia and Medigran.

	Cynosure Cynosure is a company that develops, manufactures, and markets aesthetic treatment systems.	STRATA Skin Sciences STRATA Skin Sciences is a medical technology company developing and commercializing products for the treatment of dermatological disorders.	Ellex Ellex Medical is a company that manufactures ophthalmic equipment.	Erchonia Erchonia is a company that manufactures medical laser equipment.	Medigran Medigran (Медігран) is a manufacturer and supplier of medical devices.
Founding Date	Founding Date 2004	Founding Date 1989	Founding Date 1985	Founding Date 1996	Founding Date N/A
Type	Type Private	Type Public	Type Subsidiary	Type Private	Type Private
Tags	Tags Healthcare health & beauty lasers medical devices medical diagnostics	Tags Healthcare health & beauty medical devices medical diagnostics	Tags Healthcare lasers medical devices medical diagnostics medtech	Tags Healthcare accessories lasers medical devices medical diagnostics	Tags Healthcare dental lasers medical devices medical diagnostics
Locations	Locations Langen (Hessen), DE HQ Villaviciosa De Odón, ES Westford, US	Locations Horsham, US HQ Horsham, US	Locations Pooraka, AU HQ Rillieux La Pape, FR Berlin, DE Chuo City, JP Eden Prairie, US Fremont, US	Locations Melbourne, US HQ Wallingford, GB	Locations Kyiv, UA HQ
Employees	Employees 13	Employees 1067% increase	Employees 166	Employees 602% decrease	Employees 264% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $30.7m (FY, 2025)	Revenue (est.) $29.3m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $12.8m (FY, 2025)	Cost of goods $8.6m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $17.9m (FY, 2025)	Gross profit $20.6m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ($6.3m) (FY, 2025)	Net income ($9.1m) (FY, 2025)	Net income N/A	Net income N/A